Evidence map›Paper›PMID 35365160›Full record

ReviewCell division2022

Proteolysis dependent cell cycle regulation in Caulobacter crescentus.

Nida I Fatima, Khalid Majid Fazili, Nowsheen Hamid Bhat

Open access · goldAbstract readReview
In one paragraph

Review in Cell division, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Nida I FatimaDepartment of Biotechnology, University of Kashmir, Hazratbal, Srinagar, Jammu and Kashmir, 190006, India.
Khalid Majid FaziliDepartment of Biotechnology, University of Kashmir, Hazratbal, Srinagar, Jammu and Kashmir, 190006, India.
Nowsheen Hamid BhatDepartment of Biotechnology, Central University of Kashmir, Ganderbal, Jammu and Kashmir, 191201, India. noushu78@gmail.com.ORCID http://orcid.org/0000-0003-1335-1240
University of Kashmir · INCentral University of Kashmir · IN

Funding

dst, india SR/WOS-A/LS-568/2013(G)university grants commission 921/ (CSIR-UGC NET DEC. 2016)
6 · The paper itself

Abstract

Caulobacter crescentus, a Gram-negative alpha-proteobacterium, has surfaced as a powerful model system for unraveling molecular networks that control the bacterial cell cycle. A straightforward synchronization protocol and existence of many well-defined developmental markers has allowed the identification of various molecular circuits that control the underlying differentiation processes executed at the level of transcription, translation, protein localization and dynamic proteolysis. The oligomeric AAA+ protease ClpXP is a well-characterized example of an enzyme that exerts post-translational control over a number of pathways. Also, the proteolytic pathways of its candidate proteins are reported to play significant roles in regulating cell cycle and protein quality control. A detailed evaluation of the impact of its proteolysis on various regulatory networks of the cell has uncovered various significant cellular roles of this protease in C. crescentus. A deeper insight into the effects of regulatory proteolysis with emphasis on cell cycle progression could shed light on how cells respond to environmental cues and implement developmental switches. Perturbation of this network of molecular machines is also associated with diseases such as bacterial infections. Thus, research holds immense implications in clinical translation and health, representing a promising area for clinical advances in the diagnosis, therapeutics and prognosis.

Indexed as

Cell cycle progressionCell division proteinsMolecular medicineRegulatory proteolysisTranslational health

Identifiers

PMID35365160
PMCPMC8973945
OpenAlexW4220718036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.